Panetta JC - Search Results

1

Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.

Bhojwani D, Sabin ND, Pei D, Yang JJ, Khan RB, Panetta JC, Krull KR, Inaba H, Rubnitz JE, Metzger ML, Howard SC, Ribeiro RC, Cheng C, Reddick WE, Jeha S, Sandlund JT, Evans WE, Pui CH, Relling MV. Bhojwani D, et al. Among authors: panetta jc. J Clin Oncol. 2014 Mar 20;32(9):949-59. doi: 10.1200/JCO.2013.53.0808. Epub 2014 Feb 18. J Clin Oncol. 2014. PMID: 24550419 Free PMC article.

2

Deoxythioguanosine triphosphate impairs HIV replication: a new mechanism for an old drug.

Krynetskaia NF, Feng JY, Krynetski EY, Garcia JV, Panetta JC, Anderson KS, Evans WE. Krynetskaia NF, et al. Among authors: panetta jc. FASEB J. 2001 Sep;15(11):1902-8. doi: 10.1096/fj.01-0124com. FASEB J. 2001. PMID: 11532970

3

Methotrexate intracellular disposition in acute lymphoblastic leukemia: a mathematical model of gamma-glutamyl hydrolase activity.

Panetta JC, Wall A, Pui CH, Relling MV, Evans WE. Panetta JC, et al. Clin Cancer Res. 2002 Jul;8(7):2423-9. Clin Cancer Res. 2002. PMID: 12114448

4

Limited and optimal sampling strategies for etoposide and etoposide catechol in children with leukemia.

Panetta JC, Wilkinson M, Pui CH, Relling MV. Panetta JC, et al. J Pharmacokinet Pharmacodyn. 2002 Apr;29(2):171-88. doi: 10.1023/a:1019755608555. J Pharmacokinet Pharmacodyn. 2002. PMID: 12361242

5

A mathematical model of in vivo methotrexate accumulation in acute lymphoblastic leukemia.

Panetta JC, Yanishevski Y, Pui CH, Sandlund JT, Rubnitz J, Rivera GK, Ribeiro R, Evans WE, Relling MV. Panetta JC, et al. Cancer Chemother Pharmacol. 2002 Nov;50(5):419-28. doi: 10.1007/s00280-002-0511-x. Epub 2002 Sep 24. Cancer Chemother Pharmacol. 2002. PMID: 12439601 Clinical Trial.

6

Pharmacokinetics and pharmacodynamics of oral etoposide in children with relapsed or refractory acute lymphoblastic leukemia.

Edick MJ, Gajjar A, Mahmoud HH, van de Poll ME, Harrison PL, Panetta JC, Rivera GK, Ribeiro RC, Sandlund JT, Boyett JM, Pui CH, Relling MV. Edick MJ, et al. Among authors: panetta jc. J Clin Oncol. 2003 Apr 1;21(7):1340-6. doi: 10.1200/JCO.2003.06.083. J Clin Oncol. 2003. PMID: 12663724 Clinical Trial.

7

Msh2 deficiency attenuates but does not abolish thiopurine hematopoietic toxicity in msh2-/- mice.

Krynetskaia NF, Brenner TL, Krynetski EY, Du W, Panetta JC, Ching-Hon P, Evans WE. Krynetskaia NF, et al. Among authors: panetta jc. Mol Pharmacol. 2003 Aug;64(2):456-65. doi: 10.1124/mol.64.2.456. Mol Pharmacol. 2003. PMID: 12869651

8

Late-onset delayed excretion of methotrexate.

Pauley JL, Panetta JC, Schmidt J, Kornegay N, Relling MV, Pui CH. Pauley JL, et al. Among authors: panetta jc. Cancer Chemother Pharmacol. 2004 Aug;54(2):146-52. doi: 10.1007/s00280-004-0797-y. Epub 2004 May 18. Cancer Chemother Pharmacol. 2004. PMID: 15148625

9

A substrate specific functional polymorphism of human gamma-glutamyl hydrolase alters catalytic activity and methotrexate polyglutamate accumulation in acute lymphoblastic leukaemia cells.

Cheng Q, Wu B, Kager L, Panetta JC, Zheng J, Pui CH, Relling MV, Evans WE. Cheng Q, et al. Among authors: panetta jc. Pharmacogenetics. 2004 Aug;14(8):557-67. doi: 10.1097/01.fpc.0000114761.78957.7e. Pharmacogenetics. 2004. PMID: 15284538

10

Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics.

Kager L, Cheok M, Yang W, Zaza G, Cheng Q, Panetta JC, Pui CH, Downing JR, Relling MV, Evans WE. Kager L, et al. Among authors: panetta jc. J Clin Invest. 2005 Jan;115(1):110-7. doi: 10.1172/JCI22477. J Clin Invest. 2005. PMID: 15630450 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

140 results

Search Page